Enanta Pharmaceuticals Inc (ENTA)
9.30
+0.22
(+2.42%)
USD |
NASDAQ |
Nov 21, 16:00
9.30
0.00 (0.00%)
After-Hours: 20:00
Enanta Pharmaceuticals Price to Book Value: 1.323 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2024 | 1.292 |
| November 19, 2024 | 1.340 |
| November 18, 2024 | 1.362 |
| November 15, 2024 | 1.356 |
| November 14, 2024 | 1.441 |
| November 13, 2024 | 1.484 |
| November 12, 2024 | 1.517 |
| November 11, 2024 | 1.547 |
| November 08, 2024 | 1.575 |
| November 07, 2024 | 1.615 |
| November 06, 2024 | 1.639 |
| November 05, 2024 | 1.602 |
| November 04, 2024 | 1.581 |
| November 01, 2024 | 1.558 |
| October 31, 2024 | 1.60 |
| October 30, 2024 | 1.635 |
| October 29, 2024 | 1.636 |
| October 28, 2024 | 1.648 |
| October 25, 2024 | 1.662 |
| October 24, 2024 | 1.729 |
| October 23, 2024 | 1.814 |
| October 22, 2024 | 1.850 |
| October 21, 2024 | 1.798 |
| October 18, 2024 | 1.797 |
| October 17, 2024 | 1.747 |
| Date | Value |
|---|---|
| October 16, 2024 | 1.722 |
| October 15, 2024 | 1.660 |
| October 14, 2024 | 1.609 |
| October 11, 2024 | 1.571 |
| October 10, 2024 | 1.512 |
| October 09, 2024 | 1.524 |
| October 08, 2024 | 1.565 |
| October 07, 2024 | 1.643 |
| October 04, 2024 | 1.624 |
| October 03, 2024 | 1.592 |
| October 02, 2024 | 1.601 |
| October 01, 2024 | 1.557 |
| September 30, 2024 | 1.474 |
| September 27, 2024 | 1.43 |
| September 26, 2024 | 1.490 |
| September 25, 2024 | 1.518 |
| September 24, 2024 | 1.551 |
| September 23, 2024 | 1.565 |
| September 20, 2024 | 1.605 |
| September 19, 2024 | 1.608 |
| September 18, 2024 | 1.621 |
| September 17, 2024 | 1.658 |
| September 16, 2024 | 1.680 |
| September 13, 2024 | 1.769 |
| September 12, 2024 | 1.734 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.7948
Minimum
Nov 13 2023
4.955
Maximum
Nov 05 2021
2.369
Average
2.181
Median
Price to Book Value Benchmarks
| NovaBay Pharmaceuticals Inc | 3.291 |
| Palatin Technologies Inc | -- |
| iBio Inc | 1.263 |
| Theriva Biologics Inc | 0.1446 |
| Oragenics Inc | 2.223 |
Price to Book Value Related Metrics
| PS Ratio | 2.730 |
| Price | 9.30 |
| Earnings Yield | -58.60% |
| Market Cap | 197.05M |